States placing orders for pediatric vaccine; FDA authorization expected as soon as Friday

The Food and Drug Administration is aiming to grant emergency use authorization to the Pfizer-BioNTech coronavirus vaccine for children ages 5 to 11 on Friday, according to federal officials familiar with the plans. While the Centers for Disease Control and Prevention has the final say in the vaccine’s authorization for that age group, states already are gearing up to acquire the necessary doses.